Pharmaceutical News and Articles

U.S. E-Bike and Scooter Injuries are Soaring

up by a whopping 269 .Drawing from a nationwide injury surveillance system, Burford s team looked at patterns for more than 1.9 million injuries associated with

At Two Dallas Hospitals, Kids' ER Visits for Heat Illness Nearly Tripled Over Last Decade

In a sign that climate change may be fueling heat illnesses in kids, a new study reveals that such visits to two Texas children s emergency rooms spiked 170 bet

FDA Approves New Kind of Drug for Schizophrenia

The first new type of medication in decades to help fight against schizophrenia was approved on Thursday by the U.S. Food and Drug Administration. Cobenfy (xano

Fasenra approved in the US for eosinophilic granulomatosis with polyangiitis

UCB announces U.S. FDA approvals for Bimzelx (bimekizumab-bkzx) for the treatment of psoriatic arthritis, non-radiographic axial spondyloarthritis and ankylosing spondylitis

Free COVID-19 Tests Available Now

The free COVID-19 tests promised by the U.S. government are now available. U.S. households will be eligible to order four free COVID-19 tests at COVIDTests.gov,

Childhood Vaccination Coverage Lower for Children Born in 2020, 2021

Children born in 2020 to 2021 had lower coverage with nearly all childhood vaccines recommended by age 24 months than those born in 2018 and 2019, according to

U.S. Food and Drug Administration Approves Bristol Myers Squibb’s Cobenfy (xanomeline and trospium chloride), a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults

U.S. Restarts Free COVID Test Program

Starting today, the U.S. government is offering another round of free COVID tests. U.S. households will be eligible to order 4 free COVID-19 tests at COVIDTests

Anti-CD20 Therapy Shows No Effect on Disability Progression in MS

For patients with primary progressive multiple sclerosis (PPMS), the time to confirmed disability progression (CDP) does not differ for those who are anti-CD20-